FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

CardioFocus’ Endoscopic Ablator Gains CE Mark to Treat Atrial Fibrillation

March 27, 2019
A A

CardioFocus received the CE Mark for its HeartLight X3, an endoscopic ablation system used to remove harmful tissue in the body and perform pulmonary vein isolation procedures.

The third-generation product combines a motor control system with laser energy and direct tissue visualization to block abnormal electric pathways responsible for atrial fibrillation.

Atrial fibrillation is a quivering or irregular heartbreak that can cause stroke, heart failure and other adverse events.

View today's stories